APP and Alzheimer disease: Two key miRNAs stand out: miR-29a downregulates BACE1 translation, and its downregulation correlates with increased Aβ burden [152]; and miR-193b directly targets the APP transcript, with reduced exosomal miR-193b detectable in prodromal AD [153].